About two weeks after the RECOVERY trial announced that hydroxychloroquine does not reduce deaths among hospitalised COVID-19 patients and was halting the trial, the WHO has stopped the hydroxychloroquine arm of the Solidarity trial. About two weeks after the RECOVERY trial announced that it is halting the hydroxychloroquine arm as the drug does not prevent … Continue reading WHO halts hydroxychloroquine arm of Solidarity trial
RECOVERY Trial
Dexamethasone reduces deaths in COVID-19 patients with severe complications
The RECOVERY trial has found that the steroid dexamethasone reduces deaths by one-third in COVID-19 patients on ventilator and by one-fifth in patients receiving only oxygen. No evidence of benefit was seen in patients who did not require oxygen, and it does not help prevent COVID-19. In a major breakthrough, preliminary findings from the RECOVERY … Continue reading Dexamethasone reduces deaths in COVID-19 patients with severe complications
Science Chronicle 